Bharat Biotech

company

About

India's second biggest vaccines company

Details

Last Funding Type
Private Equity(PE)
Industries
Biotechnology
Founded date
Jan 1, 1996
Number Of Employee
501 - 1000
Operating Status
Active

Bharat Biotech International Limited, a biotechnology company, engages in the research, development, and manufacture of vaccines and biotherapeutics. Its products include Revac-B+, a recombinant hepatitis-B vaccine; TYPBAR, a vi polysaccharide typhoid vaccine; BIOPOLIO, a poliomyelitis vaccine; INDIRAB, a rabies vaccine; Revac-Bmcf, a thiomersal free recombinant hepatitis-B vaccine; TEVAC, a tetanus vaccine; Scorgen, a scorpion venom anti-serum; and BioHib, a haemophilus influenza type b vaccine

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$14.10M
Bharat Biotech has raised a total of $14.10M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 3, 2020 Grant $14.10M 1 Coalition for Epidemic Preparedness Innovations Detail
Jan 1, 2019 Series Unknown 1 Subhkam Ventures Detail
Dec 16, 2016 Private Equity(PE) 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Bharat Biotech is funded by 3 investors. Coalition for Epidemic Preparedness Innovations and Subhkam Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Coalition for Epidemic Preparedness Innovations Yes Grant
Subhkam Ventures Yes Series Unknown
The Carlyle Group Private Equity(PE)

Employee Profiles

Number of Employee Profiles
4
Bharat Biotech has 4 current employee profiles, including Executive Suchitra Ella
Executive
Executive
Executive
Employee

Acquisition

Bharat Biotech has acquired 1 organizations. Their most recent acquisition was Chiron Behring Vaccines on Feb 18, 2019. They acquired Chiron Behring Vaccines for 0.

Date Company Name
Industry Acquisition Type Price
Biotechnology acquisition Detail